Learn more about clinical trials
Deciding About a Clinical Trial
If you are thinking about whether a clinical trial may be right for you, this page offers guidance to help you explore your options and prepare for conversations with your healthcare team.
Considering a Clinical Trial
Clinical trials may be offered at specialized medical centers, research hospitals, or through multi-site studies. Some trials are currently enrolling participants, while others may be in planning stages or no longer accepting new participants.
Not all trials are available in every location. Some may require travel, while others allow remote participation or limited in-person visits.
Before considering a clinical trial, it is important to talk with your healthcare team. They can help you understand whether a study may be appropriate for your diagnosis, current treatment plan, and overall health.
When reviewing a clinical trial, it may be helpful to consider:
- The purpose of the study
- What participation involves (visits, testing, time commitment)
- Possible benefits and risks
- Whether travel is required
- What costs may be covered by the study
Not every trial will be the right fit. Taking time to gather information and ask questions can help you make an informed decision.
Exploring Clinical Trials: What to Know Before You Join
If you are thinking about participating in a clinical trial, you may want to ask:
- What is the goal of this study?
- What phase is the trial?
- What are the possible risks and benefits?
- How often will visits or tests be required?
- Will I need to travel?
- What costs are covered by the study?
- Can I leave the study if I choose?
There is no “right” or “wrong” decision—only what feels right for you and your family.
Clinical Trials: Next Steps & Important Questions
Participation in a clinical trial is always voluntary. You can choose not to join a study or to leave a study at any time without affecting your standard medical care.
Not qualifying for a clinical trial is common and does not reflect disease severity or limit access to current or future treatments.
The Lymphatic Malformation Alliance does not recommend specific clinical trials but is committed to providing education and resources to help patients and families better understand their options. If you need help preparing questions or navigating information, we encourage you to speak with your healthcare team and use trusted resources.
Discover current clinical trials, registry studies, and research surveys focused on isolated lymphatic malformations and complex lymphatic anomalies. Use these resources to learn about emerging treatments and discuss potential opportunities with your healthcare provider.
STARBORN-1 Study:
This medical research study is at children's hospitals and clinics in the US and focused on the cyst in lymphatic malformations. Visit the study website, download informational flyer, or visit clinical trials website.
PTX-022 in the Treatment of Microcystic Lymphatic Malformations:
This study is to assess the change in microcystic lymphatic malformations IGA with QTORIN™ 3.9% Rapamycin Anhydrous Gel. This study has 15 locations around the US. Questions - See complete information.
Interview Survey about Vascular Malformations:
This research study is specifically looking for those with Lymphatic Malformations and PIK3CA-Related Overgrowth Spectrum. The survey is limited to the US. See complete information. (PDF)
Alpelisib in PIK3CA Associated Lymphatic Malformations:
This study is to evaluate the safety and efficacy of a drug called alpelisib in patients diagnosed with lymphatic malformations, with confirmed PIK3CA variant. See complete information.
A Prospective Natural History Study of Lymphatic Anomalies:
Find out more about the study and the eligibility criteria.
Zovegalisib (RLY-2608) Clinical Trial for PIK3CA-Related Vascular Anomalies:
Researchers are evaluating the safety of the treatment and whether it may help improve symptoms caused by these rare conditions. This is a worldwide study. See complete information
We recommend that you seek the guidance of your physician when making decisions regarding research or entering a clinical trial. This information is a resource only and the Lymphatic Malformation Alliance receives no support or compensation for the listing of research programs/clinical trials.
